Sequana Medical NV
XBRU:SEQUA
Operating Margin
Sequana Medical NV
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| BE |
|
Sequana Medical NV
XBRU:SEQUA
|
52.9m EUR |
-17 192%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
234.1B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
198.4B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
157.6B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148.8B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.8B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
55B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.6B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.8B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.8B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
272.9B CNY |
34%
|
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Sequana Medical NV's most recent financial statements, the company has Operating Margin of -17 191.5%.
You don't have any saved screeners yet